Breaking News

LabCorp Introduces Xcellerate COVID-19 Clinical Study Solution

Offers integrated data collection, actionable views of critical study data, COVID-19 targeted risk management and recovery assessment.

By: Contract Pharma

Contract Pharma Staff

LabCorp announced that Covance, its drug development business, has deployed the Xcellerate COVID-19 solution, a comprehensive approach to reinitiate ongoing research and start up new studies, with a focus on patient safety and study delivery. Designed in conjunction with Covance’s COVID-19 Operational Recovery Team, the Xcellerate COVID-19 solution offers integrated data collection, actionable views of critical study data, COVID-19 targeted risk management and recovery assessment. Global cli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters